{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:47:29Z","timestamp":1792784849938,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":35,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Imagene AI"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1038\/s41379-022-01141-4","type":"journal-article","created":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T06:02:37Z","timestamp":1662184957000},"page":"1882-1887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Direct identification of ALK and ROS1 fusions in non-small cell lung cancer from hematoxylin and eosin-stained slides using deep learning algorithms"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7871-6338","authenticated-orcid":false,"given":"Chen","family":"Mayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Ofek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Even","family":"Fridrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yossef","family":"Molchanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinat","family":"Yacobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Gazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Hayun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Zalach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurit","family":"Paz-Yaacov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Barshack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-022-01141-4_bib1","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1200\/JCO.2014.59.0489","article-title":"Overall response rate, progression-free survival, and overall survival with targeted and standard therapies in advanced non-small-cell lung cancer: US Food and Drug Administration trial-level and patient-level analyses","volume":"33","author":"Blumenthal","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-022-01141-4_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5858\/arpa.2017-0388-CP","volume":"142","author":"Lindeman","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-022-01141-4_bib3","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.6004\/jnccn.2019.0059","article-title":"NCCN guidelines insights: non-small cell lung cancer, version 1.2020","volume":"17","author":"Ettinger","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1038\/s41379-022-01141-4_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.lungcan.2022.04.001","article-title":"Mutation-tailored treatment selection in non-small cell lung cancer patients in daily clinical practice","volume":"167","author":"Steeghs","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1038\/s41379-022-01141-4_bib5","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2217\/fon-2020-0332","article-title":"Improvement strategies for successful next-generation sequencing analysis of lung cancer","volume":"16","author":"Kunimasa","year":"2020","journal-title":"Future Oncol"},{"key":"10.1038\/s41379-022-01141-4_bib6","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jtho.2020.06.006","article-title":"Molecular testing in lung cancer: still big gap in implementation for real-world use","volume":"15","author":"Ahn","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-022-01141-4_bib7","first-page":"149","article-title":"Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement","volume":"4","author":"Kim","year":"2015","journal-title":"Transl Lung Cancer Res"},{"key":"10.1038\/s41379-022-01141-4_bib8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2011.35.6345","article-title":"ROS1 rearrangements define a unique molecular class of lung cancers","volume":"30","author":"Bergethon","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-022-01141-4_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.lungcan.2014.02.007","article-title":"ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features","volume":"84","author":"Pan","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1038\/s41379-022-01141-4_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102178","article-title":"Current treatment and future challenges in ROS1- and ALK-rearranged advanced non-small cell lung cancer","volume":"95","author":"Remon","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"10.1038\/s41379-022-01141-4_bib11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fphar.2019.00230","article-title":"Advances in targeted therapy and immunotherapy for non-small cell lung cancer based on accurate molecular typing","volume":"10","author":"Dong","year":"2019","journal-title":"Front Pharm"},{"key":"10.1038\/s41379-022-01141-4_bib12","doi-asserted-by":"crossref","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-022-01141-4_bib13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2017.76.7293","volume":"36","author":"Kalemkerian","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-022-01141-4_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jclinpath-2021-207490","article-title":"Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing","volume":"75","author":"Conde","year":"2022","journal-title":"J Clin Pathol"},{"key":"10.1038\/s41379-022-01141-4_bib15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1373\/clinchem.2016.265314","article-title":"Identification of ALK, ROS1, and RET fusions by a multiplexed mRNA-based assay in formalin-fixed, paraffin-embedded samples from advanced non-small-cell lung cancer patients","volume":"63","author":"Reguart","year":"2017","journal-title":"Clin Chem"},{"key":"10.1038\/s41379-022-01141-4_bib16","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.jtho.2016.06.001","article-title":"Custom gene capture and next-generation sequencing to resolve discordant ALK status by FISH and IHC in lung adenocarcinoma","volume":"11","author":"Jang","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-022-01141-4_bib17","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.jtho.2018.05.041","article-title":"Comparison of molecular testing modalities for detection of ROS1 rearrangements in a cohort of positive patient samples","volume":"13","author":"Davies","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-022-01141-4_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jtho.2020.10.007","article-title":"Outcomes according to ALK status determined by central immunohistochemistry or fluorescence in situ hybridization in patients with ALK-positive NSCLC enrolled in the phase 3 ALEX study","volume":"16","author":"Mok","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-022-01141-4_bib19","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.jtho.2020.05.002","article-title":"The International Association for the study of lung cancer global survey on molecular testing in lung cancer","volume":"15","author":"Smeltzer","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-022-01141-4_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41568-018-0016-5","article-title":"Artificial intelligence in radiology","volume":"18","author":"Hosny","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/s41379-022-01141-4_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/jpi.jpi_24_19","article-title":"Multi-field-of-view deep learning model predicts nonsmall cell lung cancer programmed death-ligand 1 status from whole-slide hematoxylin and eosin images","volume":"10","author":"Sha","year":"2019","journal-title":"J Pathol Inf"},{"key":"10.1038\/s41379-022-01141-4_bib22","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s41591-018-0177-5","article-title":"Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning","volume":"24","author":"Coudray","year":"2018","journal-title":"Nat Med"},{"key":"10.1038\/s41379-022-01141-4_bib23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1470-2045(20)30535-0","article-title":"Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study","volume":"22","author":"Yamashita","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1038\/s41379-022-01141-4_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-64156-4","article-title":"Deep learned tissue \u201cfingerprints\u201d classify breast cancers by ER\/PR\/Her2 status from H&E images","volume":"10","author":"Rawat","year":"2020","journal-title":"Sci Rep."},{"key":"10.1038\/s41379-022-01141-4_bib25","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1158\/1078-0432.CCR-17-2452","article-title":"Resistance mechanisms to targeted therapies in ROS1(+) and ALK(+) non-small cell lung cancer","volume":"24","author":"McCoach","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-022-01141-4_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jtho.2017.12.001","volume":"13","author":"Lindeman","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-022-01141-4_bib27","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/jamaoncol.2019.0453","article-title":"Next generation sequencing-testing multiple genetic markers at once","volume":"5","author":"Ewalt","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1038\/s41379-022-01141-4_bib28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/resp.13823","article-title":"Is tissue still the issue in detecting molecular alterations in lung cancer?","volume":"25","author":"Liam","year":"2020","journal-title":"Respirology"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01141-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01141-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222055004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222055004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01141-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:23:47Z","timestamp":1760232227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222055004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0893395222055004"],"URL":"https:\/\/doi.org\/10.1038\/s41379-022-01141-4","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct identification of ALK and ROS1 fusions in non-small cell lung cancer from hematoxylin and eosin-stained slides using deep learning algorithms","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-022-01141-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}]}}